Beclometasone dipropionate 100 mcg, formoterol fumarate dihydrate 6 mcg (equiv to a delivered dose of 84.6 mcg & 5 mcg, respectively)
Indications/Uses
Asthma in patients adequately & not adequately controlled w/ inhaled corticosteroids, short- & long-acting β2-acting agonist. Symptomatic treatment of patients w/ severe COPD (FEV1 <50% predicted normal) & a history of repeated exacerbations, who have significant symptoms despite regular therapy w/ long-acting bronchodilators.
Asthma Adult ≥18 yr Maintenance therapy: 1 or 2 inhalations bid. Max daily dose: 4 inhalations. Maintenance & reliever therapy: 1 inhalation bid (1 inhalation in the morning & in the evening). 1 additional inhalation as needed in response to symptoms. If symptoms persist after a few min, an additional inhalation should be taken. Max daily dose: 8 inhalations. COPD 2 inhalations bid.
Cardiac arrhythmias especially 3rd-degree AV block & tachyarrhythmias, idiopathic subvalvular aortic stenosis, hypertrophic obstructive cardiomyopathy, severe heart & occlusive vascular disease. Known or suspected prolongation of the QTc interval either congenital or drug induced (QTc >0.44 sec). Thyrotoxicosis, DM, phaeochromocytoma & untreated hypokalaemia. Severe asthma; monitor serum K levels in unstable asthma. Monitor blood glucose closely in diabetics. Do not administer at least 12 hr prior to anesth. Active or quiescent pulmonary TB, fungal & viral infections in the airways. Avoid abrupt w/drawal. Discontinue use if paradoxical bronchospasm occurs. Transfer to Foster therapy of patients w/ impaired adrenal function from previous systemic steroid therapy. Childn & adolescents <18 yr. Pregnancy & lactation.
R03AK08 - formoterol and beclometasone ; Belongs to the class of adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics. Used in the treatment of obstructive airway diseases.
Sign Out
